Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study: gender and risk of POAG in African Americans.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
18
12
2018
accepted:
10
06
2019
entrez:
2
8
2019
pubmed:
2
8
2019
medline:
4
3
2020
Statut:
epublish
Résumé
The purpose of this study was to investigate the association between gender and primary open-angle glaucoma (POAG) among African Americans and to assess demographic, systemic, and behavioral factors that may contribute to differences between genders. The Primary Open-Angle African American Glaucoma Genetics (POAAGG) study had a case-control design and included African Americans 35 years and older, recruited from the greater Philadelphia, Pennsylvania. Diagnosis of POAG was based on evidence of both glaucomatous optic nerve damage and characteristic visual field loss. Demographic and behavioral information, history of systemic diseases and anthropometric measurements were obtained at study enrollment. Gender differences in risk of POAG were examined using multivariate logistic regression. A total of 2,290 POAG cases and 2,538 controls were included in the study. The percentage of men among cases was higher than among controls (38.6% vs 30.3%, P<0.001). The subjects' mean age at enrollment was significantly higher for cases compared to controls (70.2±11.3 vs. 61.6±11.8 years, P<0.003). Cases had lower rates of diabetes (40% vs. 46%, P<0.001), higher rates of systemic hypertension (80% vs. 72%, P<0.001), and lower body mass index (BMI) (29.7±6.7 vs. 31.9±7.4, P<0.001) than controls. In the final multivariable model, male gender was significantly associated with POAG risk (OR, 1.64; 95% CI, 1.44-1.87; P<0.001), after adjusting for age, systemic hypertension, diabetes, and BMI. Within the POAAGG study, men were at higher risk of having POAG than women. Pending genetic results from this study will be used to better understand the underlying genetic variations that may account for these differences.
Identifiants
pubmed: 31369581
doi: 10.1371/journal.pone.0218804
pii: PONE-D-18-36115
pmc: PMC6675103
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0218804Subventions
Organisme : NEI NIH HHS
ID : L30 EY029353
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001583
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY023557
Pays : United States
Organisme : NEI NIH HHS
ID : K12 EY015398
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY029765
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Epidemiol. 2001 Feb;54(2):166-71
pubmed: 11166532
Am J Epidemiol. 2001 Jul 15;154(2):138-44
pubmed: 11447046
Ophthalmology. 2001 Nov;108(11):1966-72
pubmed: 11713063
Arch Ophthalmol. 2001 Dec;119(12):1819-26
pubmed: 11735794
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Br J Ophthalmol. 1975 Dec;59(12):717-20
pubmed: 1218183
Am J Epidemiol. 1977 Jul;106(1):33-41
pubmed: 141882
J Glaucoma. 2004 Aug;13(4):319-26
pubmed: 15226661
Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2224-8
pubmed: 1607232
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Arch Ophthalmol. 2007 Jun;125(6):805-12
pubmed: 17562992
Ophthalmology. 2008 Jan;115(1):85-93
pubmed: 17629563
Ophthalmology. 2008 Apr;115(4):639-647.e2
pubmed: 17900693
J Glaucoma. 2007 Oct-Nov;16(7):598-605
pubmed: 18091177
Am J Epidemiol. 2008 Jun 1;167(11):1287-94
pubmed: 18359953
Arch Ophthalmol. 2009 Oct;127(10):1354-61
pubmed: 19822853
Middle East Afr J Ophthalmol. 2009 Jul;16(3):146-50
pubmed: 20142982
Arch Gynecol Obstet. 2011 Mar;283(3):569-73
pubmed: 20213131
JAMA. 1991 Jul 17;266(3):369-74
pubmed: 2056646
Br J Ophthalmol. 2010 Jul;94(7):827-30
pubmed: 20606021
Am J Obstet Gynecol. 2011 Oct;205(4):353.e1-8
pubmed: 21663888
Menopause. 2012 Aug;19(8):942-7
pubmed: 22415565
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5028-34
pubmed: 23821204
Curr Eye Res. 2015 Feb;40(2):201-12
pubmed: 24892919
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Ophthalmology. 2015 Apr;122(4):711-20
pubmed: 25576993
Maturitas. 2016 Jan;83:19-26
pubmed: 26508081
Ophthalmology. 2016 Apr;123(4):771-82
pubmed: 26795295
Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2905–2913
pubmed: 27168366
Ethn Health. 2019 Aug;24(6):694-704
pubmed: 28669230
Arch Ophthalmol. 1995 Jul;113(7):918-24
pubmed: 7605285
Ophthalmology. 1994 Nov;101(11):1851-5
pubmed: 7800368
Arch Ophthalmol. 1994 Jun;112(6):821-9
pubmed: 8002842
Arch Ophthalmol. 1994 Aug;112(8):1068-76
pubmed: 8053821
Nutr Cancer. 1994;21(3):247-61
pubmed: 8072878
Am J Epidemiol. 1994 Apr 15;139(8):813-8
pubmed: 8178794
Ophthalmology. 1996 Oct;103(10):1661-9
pubmed: 8874440
Bull Soc Belge Ophtalmol. 1997;267:29-34
pubmed: 9745811